Tapewire

Nasdaq · USD

AVIR

Atea Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
5580
SEC CIK
0001593899
Parsed reports
127

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2024 Filed Jun 18, 2024 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074985 · ownership.xml · derivative · entry 2

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units are fully vested.

F3 · derivative.expiration_date: The restricted stock units do not have an expiration date.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC Exercise / conversionCommon Stock 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074985 · ownership.xml · nonDerivative · entry 1

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074987 · ownership.xml · derivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units are fully vested.

F3 · derivative.expiration_date: The restricted stock units do not have an expiration date.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC Exercise / conversionCommon Stock 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074987 · ownership.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 811,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC Exercise / conversionRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074989 · ownership.xml · derivative · entry 2

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock unites are fully vested.

F3 · derivative.expiration_date: The restricted stock units do not have an expiration date.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC Exercise / conversionCommon Stock 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074989 · ownership.xml · nonDerivative · entry 1

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC
Lucidi BrunoDirector
Exercise / conversionRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074988 · ownership.xml · derivative · entry 2

Lucidi Bruno · CIK 0001829622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units are fully vested.

F3 · derivative.expiration_date: The restricted stock units do not have an expiration date.

Read SEC document
June 16, 2024 Filed Jun 18, 2024 21:00 UTC
Lucidi BrunoDirector
Exercise / conversionCommon Stock 33,150 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-074988 · ownership.xml · nonDerivative · entry 1

Lucidi Bruno · CIK 0001829622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 18:34 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
SaleCommon Stock 1,006 $4.00 $4,024.00
Disclosure

SEC source: 0000950170-24-070965 · ownership.xml · nonDerivative · entry 1

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Plan reported

Ownership: Indirect · Held by JPM Partners LLC

Disclosed balance after: 5,923,994

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:26 UTC
Foster WayneEVP, Chief Accounting Officer
SaleCommon Stock 12,477 $3.84 $47,904.19
Disclosure

SEC source: 0000950170-24-010969 · ownership.xml · nonDerivative · entry 2

Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,857

F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 15, 2022.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:30 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
SaleCommon Stock 56,910 $3.85 $218,818.95
Disclosure

SEC source: 0000950170-24-010972 · ownership.xml · nonDerivative · entry 2

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,557

F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated May 18, 2023.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:31 UTC
Corcoran AndreaSee Remarks
SaleCommon Stock 15,843 $3.84 $60,914.75
Disclosure

SEC source: 0000950170-24-010973 · ownership.xml · nonDerivative · entry 2

Corcoran Andrea · CIK 0001296996 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 670,208

F3 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022.

Read SEC document
February 01, 2024 Filed Feb 3, 2024 02:29 UTC
Horga Maria ArantxaChief Medical Officer
SaleCommon Stock 15,870 $3.84 $60,963.02
Disclosure

SEC source: 0000950170-24-010970 · ownership.xml · nonDerivative · entry 2

Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,664

F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022.

Read SEC document
February 01, 2024 Filed Feb 3, 2024 02:25 UTC
Vavricka JohnChief Commercial Officer
SaleCommon Stock 11,819 $3.84 $45,420.42
Disclosure

SEC source: 0000950170-24-010968 · ownership.xml · nonDerivative · entry 2

Vavricka John · CIK 0001829630 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,515

F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 25, 2022.

Read SEC document
February 01, 2024 Filed Feb 3, 2024 02:24 UTC
Hammond Janet MJChief Development Officer
SaleCommon Stock 14,029 $3.84 $53,913.45
Disclosure

SEC source: 0000950170-24-010967 · ownership.xml · nonDerivative · entry 2

Hammond Janet MJ · CIK 0001829899 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,362

F3 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:26 UTC
Foster WayneEVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 120,100 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0000950170-24-010969 · ownership.xml · derivative · entry 4

Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,100

Underlying: Common Stock · 120,100 shares

Expires 2034-01-30

F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:26 UTC
Foster WayneEVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 33,334 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010969 · ownership.xml · derivative · entry 3

Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,666

Underlying: Common Stock · 33,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

F3 · derivative.expiration_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:26 UTC
Foster WayneEVP, Chief Accounting Officer
Exercise / conversionCommon Stock 33,334 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-010969 · ownership.xml · nonDerivative · entry 1

Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:30 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
GrantStock Option (Right to Buy) · Derivative 448,000 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0000950170-24-010972 · ownership.xml · derivative · entry 5

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 448,000

Underlying: Common Stock · 448,000 shares

Expires 2034-01-30

F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:30 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
Exercise / conversionRestricted Stock Units · Derivative 173,467 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010972 · ownership.xml · derivative · entry 4

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,933

Underlying: Common Stock · 173,467 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The original grant of 520,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

F3 · derivative.expiration_date: The original grant of 520,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:30 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
Exercise / conversionCommon Stock 173,467 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-010972 · ownership.xml · nonDerivative · entry 1

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 173,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:31 UTC
Corcoran AndreaSee Remarks
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0000950170-24-010973 · ownership.xml · derivative · entry 4

Corcoran Andrea · CIK 0001296996 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-01-30

F5 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:31 UTC
Corcoran AndreaSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 44,367 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010973 · ownership.xml · derivative · entry 3

Corcoran Andrea · CIK 0001296996 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,733

Underlying: Common Stock · 44,367 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

F4 · derivative.expiration_date: The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 21:31 UTC
Corcoran AndreaSee Remarks
Exercise / conversionCommon Stock 44,367 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-010973 · ownership.xml · nonDerivative · entry 1

Corcoran Andrea · CIK 0001296996 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 686,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · balance_after: Includes 8,680 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:29 UTC
Horga Maria ArantxaChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 192,800 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0000950170-24-010970 · ownership.xml · derivative · entry 4

Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,800

Underlying: Common Stock · 192,800 shares

Expires 2034-01-30

F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:29 UTC
Horga Maria ArantxaChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 41,534 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010970 · ownership.xml · derivative · entry 3

Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,066

Underlying: Common Stock · 41,534 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The original grant of 124,600 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

F3 · derivative.expiration_date: The original grant of 124,600 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:29 UTC
Horga Maria ArantxaChief Medical Officer
Exercise / conversionCommon Stock 41,534 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-010970 · ownership.xml · nonDerivative · entry 1

Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:25 UTC
Vavricka JohnChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 132,800 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0000950170-24-010968 · ownership.xml · derivative · entry 5

Vavricka John · CIK 0001829630 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,800

Underlying: Common Stock · 132,800 shares

Expires 2034-01-30

F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:25 UTC
Vavricka JohnChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 33,334 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010968 · ownership.xml · derivative · entry 4

Vavricka John · CIK 0001829630 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,666

Underlying: Common Stock · 33,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

F3 · derivative.expiration_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:25 UTC
Vavricka JohnChief Commercial Officer
Exercise / conversionCommon Stock 33,334 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-010968 · ownership.xml · nonDerivative · entry 1

Vavricka John · CIK 0001829630 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:24 UTC
Hammond Janet MJChief Development Officer
GrantStock Option (Right to Buy) · Derivative 225,200 $0.00 Strike: $4.16 $0.00
Disclosure

SEC source: 0000950170-24-010967 · ownership.xml · derivative · entry 4

Hammond Janet MJ · CIK 0001829899 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,200

Underlying: Common Stock · 225,200 shares

Expires 2034-01-30

F5 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:24 UTC
Hammond Janet MJChief Development Officer
Exercise / conversionRestricted Stock Units · Derivative 46,800 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010967 · ownership.xml · derivative · entry 3

Hammond Janet MJ · CIK 0001829899 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,600

Underlying: Common Stock · 46,800 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

F4 · derivative.expiration_date: The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 02:24 UTC
Hammond Janet MJChief Development Officer
Exercise / conversionCommon Stock 46,800 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-010967 · ownership.xml · nonDerivative · entry 1

Hammond Janet MJ · CIK 0001829899 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,391

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · balance_after: Includes 2,591 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantStock Option (Right to Buy) · Derivative 46,750 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-23-016130 · doc4.xml · derivative · entry 2

Adams Jerome M. · CIK 0001863366 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Common Stock · 46,750 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016130 · doc4.xml · derivative · entry 1

Adams Jerome M. · CIK 0001863366 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 33,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC
Polsky BruceDirector
GrantStock Option (Right to Buy) · Derivative 46,750 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-23-016128 · doc4.xml · derivative · entry 2

Polsky Bruce · CIK 0001508458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Common Stock · 46,750 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC
Polsky BruceDirector
GrantRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016128 · doc4.xml · derivative · entry 1

Polsky Bruce · CIK 0001508458 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 33,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantStock Option (Right to Buy) · Derivative 46,750 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-23-016127 · doc4.xml · derivative · entry 2

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Common Stock · 46,750 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016127 · doc4.xml · derivative · entry 1

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 33,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantStock Option (Right to Buy) · Derivative 46,750 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-23-016131 · doc4.xml · derivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Common Stock · 46,750 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016131 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 33,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantStock Option (Right to Buy) · Derivative 46,750 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-23-016129 · doc4.xml · derivative · entry 2

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Common Stock · 46,750 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC GrantRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016129 · doc4.xml · derivative · entry 1

Murphy Polly A. · CIK 0001829248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 33,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC
Lucidi BrunoDirector
GrantStock Option (Right to Buy) · Derivative 46,750 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0000899243-23-016126 · doc4.xml · derivative · entry 2

Lucidi Bruno · CIK 0001829622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,750

Underlying: Common Stock · 46,750 shares

Expires 2033-06-15

F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:05 UTC
Lucidi BrunoDirector
GrantRestricted Stock Units · Derivative 33,150 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-016126 · doc4.xml · derivative · entry 1

Lucidi Bruno · CIK 0001829622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,150

Underlying: Common Stock · 33,150 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 18:38 UTC
Foster WayneEVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 140,000 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000899243-23-003629 · doc4.xml · derivative · entry 2

Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2033-01-30

F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 18:38 UTC
Foster WayneEVP, Chief Accounting Officer
GrantRestricted Stock Units · Derivative 100,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-003629 · doc4.xml · derivative · entry 1

Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.

F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 18:33 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
GrantStock Option (Right to Buy) · Derivative 728,600 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000899243-23-003615 · doc4.xml · derivative · entry 2

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 728,600

Underlying: Common Stock · 728,600 shares

Expires 2033-01-30

F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 18:33 UTC
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
GrantRestricted Stock Units · Derivative 520,400 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-003615 · doc4.xml · derivative · entry 1

Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 520,400

Underlying: Common Stock · 520,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.

F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026.

Read SEC document
January 31, 2023 Filed Feb 2, 2023 18:30 UTC
Corcoran AndreaSee Remarks
GrantStock Option (Right to Buy) · Derivative 186,300 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000899243-23-003607 · doc4.xml · derivative · entry 2

Corcoran Andrea · CIK 0001296996 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,300

Underlying: Common Stock · 186,300 shares

Expires 2033-01-30

F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.